AzTrials
AzTrials

Lower-limb Muscle Mass and Balance PerformanceLMBPNCT07365605

Lower-Limb Muscle Mass and Balance Performance

An observational study of Lower-limb Muscle Mass and Balance Performance, run by Uludag University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will examine the interaction between lower-limb muscle mass and balance performance in moderately physically active young men. Body composition parameters, including appendicular skeletal muscle mass, leg muscle mass, and the ratio of lower-limb muscle mass to body weight (LMM/BW), will be assessed using… Read more about this study

Who is it for?
Ages 20 to 32 years, men onlyHealthy volunteers can take part
How many people
150 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Feb 2026to 3 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 32 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Study population: Eskisehir, TURKEY

Who may be able to join

  • Inclusion criteria required that participants (i) were between 20 and 30 years of age; (ii) had no lower-limb injuries that could affect test performance; (iii) were moderately physically active; and (iv) had not used ergogenic aids or stimulant substances for at least six months prior to the study.

Who cannot join

  • Exclusion criteria included the presence of back, neck, leg, foot, or upper-limb pain within the previous six months, as well as a history of major orthopedic surgery involving the lower extremities or trunk.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Aeromedical Research And Training Center (ARTC)

    Eskişehir

Other trials in Turkey (Türkiye)

About this study

Official title: INTERACTION BETWEEN MUSCLE MASS AND BALANCE PERFORMANCE: A LOWER-LIMB-FOCUSED ANALYSIS

This study will examine the interaction between lower-limb muscle mass and balance performance in moderately physically active young men. Body composition parameters, including appendicular skeletal muscle mass, leg muscle mass, and the ratio of lower-limb muscle mass to body weight (LMM/BW), will be assessed using bioelectrical impedance analysis. Balance performance will be evaluated using a center-of-pressure-based static balance test, with classifications derived from sway path length and sway area parameters.

Participants will be grouped according to balance performance metrics, and muscle mass indicators will be compared between balance-based groups. Correlation analyses will also be conducted to explore associations between muscle mass variables and balance outcomes across the entire sample. It is anticipated that normalized muscle mass indicators, particularly LMM/BW, will demonstrate greater discriminative sensitivity than absolute muscle mass measures in relation to balance performance. The findings are expected to contribute to a more precise understanding of how relative lower-limb muscular capacity relates to postural control in young, physically active populations.

Read the detailed description

This study will employ a cross-sectional observational design to investigate the relationship between lower-limb muscle mass and balance performance in moderately physically active young men. The primary focus will be to determine whether normalized muscle mass indicators, particularly the ratio of lower-limb muscle mass to body weight (LMM/BW), demonstrate greater sensitivity in explaining balance-performance differences than absolute muscle mass measures.

A cohort of healthy male participants aged 20-30 years will be recruited. All participants will be moderately physically active and free from musculoskeletal injuries, neurological disorders, or medical conditions that could affect balance performance. After providing written informed consent, participants will undergo standardized anthropometric and body composition assessments using bioelectrical impedance analysis to obtain appendicular skeletal muscle mass, leg muscle mass, total muscle mass, body fat percentage, and LMM/BW.

Balance performance will be evaluated using a center-of-pressure-based static balance test performed on a stabilometric platform. Participants will complete a 30-second quiet standing task, during which sway path length and sway area will be recorded as primary balance outcomes. These parameters will be used to classify participants into balance-performance-based groups in order to examine the discriminative capacity of different balance metrics with respect to muscle mass variables.

Between-group comparisons of muscle mass indicators will be conducted to identify differences associated with balance performance classifications. In addition, correlation analyses will be performed across the entire sample to assess the strength and direction of associations between muscle mass variables and balance outcomes. Effect size estimates will be calculated to support the interpretation of observed differences.

The study is expected to clarify whether relative lower-limb muscular capacity provides a more functionally meaningful explanation of balance performance than absolute muscle mass in young, physically active populations. The findings may contribute to improved methodological approaches in balance assessment and support the use of normalized muscle mass indicators in sports science, exercise physiology, and preventive health contexts.

Keywords
Balance performance, Relative muscle mass, Lower-limb muscles, Postural stability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07365605
Study groupRoleWhat they receive
Lower Balance Performance Group (LBP)This cohort will include moderately physically active young men who exhibit higher sway path length values during a 30-second center-of-pressure-based static balance test, indicating lower balance performance. Participants in this group will have no musculoskeletal, neurological, or medical conditions affecting postural control. This cohort will be used to examine muscle mass characteristics associated with relatively poorer balance performance.
Higher Balance Performance Group (HBP)This cohort will include moderately physically active young men who exhibit lower sway path length values during a 30-second center-of-pressure-based static balance test, indicating higher balance performance. Participants in this group will be free from conditions that may influence balance outcomes. This cohort will be used to evaluate muscle mass characteristics associated with relatively better balance performance.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Balance performance assessed by center-of-pressure sway path length

    Balance performance will be quantified using center-of-pressure sway path length recorded during a 30-second quiet standing test on a stabilometric platform. Sway path length will represent the total displacement of the center of pressure over the trial duration, with higher values indicating poorer balance performance. This measure will serve as the primary balance outcome for group classification and for association analyses with lower-limb muscle mass indicators.

    Measured: Day 1 (Assessed during a single laboratory testing session)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2026
  2. Study start26 Feb 2026
  3. Primary completion30 May 2026
  4. Study completion3 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07365605
Sponsor's protocol ID
E-87914409-050.04-117156
Acronym
LMBP
Status last verified
Feb 2026
First submitted
16 Jan 2026
Last updated
8 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This study will use a cross-sectional observational design to examine the relationship between lower-limb muscle mass and balance performance in moderately physically active young men. Participants will complete standardized body composition assessments and a center-of-pressure-based static balance test during a single laboratory visit. Based on sway path length values, participants will be classified into lower and higher balance performance groups. Comparisons of muscle mass indicators, including absolute and normalized measures, will be conducted between balance-performance-based groups. In addition, associations between muscle mass variables and balance outcomes will be analyzed across the full sample to evaluate the relative explanatory value of different muscle mass indicators. The study plan is intended to determine whether normalized lower-limb muscle mass measures provide greater sensitivity for explaining balance performance differences than absolute muscle mass measures.

Publications

  • Lesinski M, Hortobagyi T, Muehlbauer T, Gollhofer A, Granacher U. Effects of Balance Training on Balance Performance in Healthy Older Adults: A Systematic Review and Meta-analysis. Sports Med. 2015 Dec;45(12):1721-38. doi: 10.1007/s40279-015-0375-y.

    PubMed 26325622
  • Granacher, U., Gollhofer, A., & Hortobágyi, T. (2013). Effects of strength training on balance ability in older adults: A systematic review and meta-analysis. Sports Medicine, 43(6), 515-529. https://doi.org/10.1007/s40279-013-0045-y

  • Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.

    PubMed 30312372
  • Calbet JA, Radegran G, Boushel R, Saltin B. On the mechanisms that limit oxygen uptake during exercise in acute and chronic hypoxia: role of muscle mass. J Physiol. 2009 Jan 15;587(2):477-90. doi: 10.1113/jphysiol.2008.162271. Epub 2008 Dec 1.

    PubMed 19047206
  • Bohannon RW, Bubela DJ, Magasi SR, Wang YC, Gershon RC. Sit-to-stand test: Performance and determinants across the age-span. Isokinet Exerc Sci. 2010;18(4):235-240. doi: 10.3233/IES-2010-0389.

    PubMed 25598584

Questions about this trial

What is this clinical trial studying?

An observational study of Lower-limb Muscle Mass and Balance Performance, run by Uludag University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Balance performance assessed by center-of-pressure sway path length (time frame: Day 1 (Assessed during a single laboratory testing session)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07365605, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in